The majority of research has shown that the miRNA/HMGA2 axis has important roles in tumor progression; however, there has been a lack of investigation into the role of miRNA/HMGA2 signaling in chemotherapeutic resistance of BC. The gene discussed is HMGA2; the disease is breast cancer.